Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Cardiovascular Revascularization Medicine : Including Molecular Interventions
|
November 3, 2018
Long-Term Outcomes of Left Main Bifurcation Double Stenting in Patients with STEMI and Cardiogenic Shock
Gianluca Rigatelli, Marco Zuin, Huy Dinh, et al.
International Journal of Oncology
|
June 7, 2024
Complement regulatory protein CD46 promotes bladder cancer metastasis through activation of MMP9
Thuy Nguyen Thi, Hien Duong Thanh, Van-Tan Nguyen, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions
|
May 1, 2018
Usefulness of the Finet law to guide stent size selection in ostial left main stenting: Comparison with standard angiographic estimation
Gianluca Rigatelli, Marco Zuin, Federico Ronco, et al.
Anticancer Research
|
April 28, 2026
Inhibition of AP-1 Reduces CD46-mediated Invasion of Bladder and Colon Cancer Cells
Thuy Nguyen Thi, VAN-Tan Nguyen, Hien Duong Thanh, et al.
Journal of Hematology & Oncology
|
October 28, 2025
Challenges and limitations of chimeric antigen receptor T-cell therapies in solid tumors: why are approvals restricted to hematologic malignancies?
Manh-Cuong Vo, Van-Dinh-Huan Tran, Van-Tan Nguyen, et al.
Cancer Immunology, Immunotherapy : CII
|
March 8, 2025
Combination therapy with expanded natural killer cells and atezolizumab exerts potent antitumor immunity in small cell lung cancer
Manh-Cuong Vo, Van-Tan Nguyen, Van-Dinh-Huan Tran, et al.
Cytotherapy
|
December 24, 2023
Efficacy of natural killer cell therapy combined with chemoradiotherapy in murine models of head and neck squamous cell carcinoma
Eun Kyung Jung, Tan-Huy Chu, Sun-Ae Kim, et al.
Translational Oncology
|
July 25, 2025
Expanded and activated marrow-infiltrating lymphocytes exhibit potent antimyeloma activity against autologous multiple myeloma cells
Seo-Yeon Ahn, Manh-Cuong Vo, Van-Tan Nguyen, et al.
Heliyon
|
March 25, 2024
Exploring cellular immunotherapy platforms in multiple myeloma
Manh-Cuong Vo, Sung-Hoon Jung, Van-Tan Nguyen, et al.
Cancer Immunology, Immunotherapy : CII
|
May 21, 2026
Overcoming resistance in CD44-overexpressing myeloma through combination therapy with ATRA, bortezomib, and NK cells
Van-Tan Nguyen, Thuy Nguyen Thi, Van-Dinh-Huan Tran, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Cardiovascular Revascularization Medicine : Including Molecular Interventions
|
November 3, 2018
Long-Term Outcomes of Left Main Bifurcation Double Stenting in Patients with STEMI and Cardiogenic Shock
Gianluca Rigatelli, Marco Zuin, Huy Dinh, et al.
International Journal of Oncology
|
June 7, 2024
Complement regulatory protein CD46 promotes bladder cancer metastasis through activation of MMP9
Thuy Nguyen Thi, Hien Duong Thanh, Van-Tan Nguyen, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions
|
May 1, 2018
Usefulness of the Finet law to guide stent size selection in ostial left main stenting: Comparison with standard angiographic estimation
Gianluca Rigatelli, Marco Zuin, Federico Ronco, et al.
Anticancer Research
|
April 28, 2026
Inhibition of AP-1 Reduces CD46-mediated Invasion of Bladder and Colon Cancer Cells
Thuy Nguyen Thi, VAN-Tan Nguyen, Hien Duong Thanh, et al.
Journal of Hematology & Oncology
|
October 28, 2025
Challenges and limitations of chimeric antigen receptor T-cell therapies in solid tumors: why are approvals restricted to hematologic malignancies?
Manh-Cuong Vo, Van-Dinh-Huan Tran, Van-Tan Nguyen, et al.
Cancer Immunology, Immunotherapy : CII
|
March 8, 2025
Combination therapy with expanded natural killer cells and atezolizumab exerts potent antitumor immunity in small cell lung cancer
Manh-Cuong Vo, Van-Tan Nguyen, Van-Dinh-Huan Tran, et al.
Cytotherapy
|
December 24, 2023
Efficacy of natural killer cell therapy combined with chemoradiotherapy in murine models of head and neck squamous cell carcinoma
Eun Kyung Jung, Tan-Huy Chu, Sun-Ae Kim, et al.
Translational Oncology
|
July 25, 2025
Expanded and activated marrow-infiltrating lymphocytes exhibit potent antimyeloma activity against autologous multiple myeloma cells
Seo-Yeon Ahn, Manh-Cuong Vo, Van-Tan Nguyen, et al.
Heliyon
|
March 25, 2024
Exploring cellular immunotherapy platforms in multiple myeloma
Manh-Cuong Vo, Sung-Hoon Jung, Van-Tan Nguyen, et al.
Cancer Immunology, Immunotherapy : CII
|
May 21, 2026
Overcoming resistance in CD44-overexpressing myeloma through combination therapy with ATRA, bortezomib, and NK cells
Van-Tan Nguyen, Thuy Nguyen Thi, Van-Dinh-Huan Tran, et al.
Page
of 1